HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy

[1] Meffre C(2010)Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors J Med Virol 82 546-555

[2] Le Strat Y(2015)The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014 PLoS One 10 e0126920-1449

[3] Delarocque-Astagneau E(2016)2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV Liver Int 36 1442-792

[4] Dubois F(2010)Routine HIV screening in France: clinical impact and cost-effectiveness PLoS One 5 785-926

[5] Antona D(2018)Assessing the cost-effectiveness of hepatitis C screening strategies in France J Hepatol 69 e180-1095

[6] Lemasson JM(2018)Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016) JMIR Research Protocols 7 916-43

[7] Brouard C(2018)New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings J Hepatol 69 1087-40

[8] Le Strat Y(2016)Dried blood spots: a tool to ensure broad access to hepatitis C screening, diagnosis, and treatment monitoring J Infect Dis 213 25-730

[9] Larsen C(2007)On the construction of imputation classes in surveys Int Stat Rev 75 33-48

[10] Jauffret-Roustide M(1997)Diagnostics for formation of nonresponse adjustment cells, with an application to income nonresponse in the US consumer expenditure survey Surv Methodol 23 139-473

[1] Meffre C(2010)Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors J Med Virol 82 546-555

[2] Le Strat Y(2015)The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014 PLoS One 10 e0126920-1449

[3] Delarocque-Astagneau E(2016)2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV Liver Int 36 1442-792

[4] Dubois F(2010)Routine HIV screening in France: clinical impact and cost-effectiveness PLoS One 5 785-926

[5] Antona D(2018)Assessing the cost-effectiveness of hepatitis C screening strategies in France J Hepatol 69 e180-1095

[6] Lemasson JM(2018)Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016) JMIR Research Protocols 7 916-43

[7] Brouard C(2018)New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings J Hepatol 69 1087-40

[8] Le Strat Y(2016)Dried blood spots: a tool to ensure broad access to hepatitis C screening, diagnosis, and treatment monitoring J Infect Dis 213 25-730

[9] Larsen C(2007)On the construction of imputation classes in surveys Int Stat Rev 75 33-48

[10] Jauffret-Roustide M(1997)Diagnostics for formation of nonresponse adjustment cells, with an application to income nonresponse in the US consumer expenditure survey Surv Methodol 23 139-473